$26.07
0[0.00%]
Last update: 4:02PM Get Real Time Here
Surmodics
(NASDAQ:SRDX)Surmodics Stock (NASDAQ:SRDX), Analyst Ratings, Price Targets, Predictions
Surmodics Inc has a consensus price target of $59, established from looking at the 16 latest analyst ratings. The last 3 analyst ratings were released from Needham, Needham, and Barrington Research on April 10, 2024, February 1, 2024, and November 9, 2023. With an average price target of $55 between Needham, Needham, and Barrington Research, there's an implied 116.71% upside for Surmodics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Barrington Research
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Surmodics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/10/2024 | SRDX | Buy Now | Surmodics | $25.38 | 85.19% | Needham | Mike Matson | → $47 | Reiterates | Buy → Buy | Get Alert |
| 02/01/2024 | SRDX | Buy Now | Surmodics | $25.38 | 85.19% | Needham | Mike Matson | $44 → $47 | Maintains | Buy | Get Alert |
| 11/09/2023 | SRDX | Buy Now | Surmodics | $25.38 | 179.75% | Barrington Research | Michael Petusky | $69 → $71 | Maintains | Outperform | Get Alert |
| 11/08/2023 | SRDX | Buy Now | Surmodics | $25.38 | 73.36% | Needham | Mike Matson | $50 → $44 | Maintains | Buy | Get Alert |
| 08/02/2023 | SRDX | Buy Now | Surmodics | $25.38 | 97.01% | Needham | Mike Matson | $36 → $50 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2023 | SRDX | Buy Now | Surmodics | $25.38 | 171.87% | Barrington Research | Michael Petusky | $60 → $69 | Maintains | Outperform | Get Alert |
| 06/20/2023 | SRDX | Buy Now | Surmodics | $25.38 | 41.84% | Needham | Mike Matson | → $36 | Reiterates | Buy → Buy | Get Alert |
| 06/13/2023 | SRDX | Buy Now | Surmodics | $25.38 | 41.84% | Needham | Mike Matson | → $36 | Upgrade | Hold → Buy | Get Alert |
| 02/13/2023 | SRDX | Buy Now | Surmodics | $25.38 | — | Needham | Mike Matson | — | Downgrade | Buy → Hold | Get Alert |
| 02/07/2023 | SRDX | Buy Now | Surmodics | $25.38 | 136.41% | Barrington Research | Michael Petusky | $61 → $60 | Maintains | Outperform | Get Alert |
| 02/07/2023 | SRDX | Buy Now | Surmodics | $25.38 | 33.96% | Needham | Mike Matson | $46 → $34 | Maintains | Buy | Get Alert |
| 01/20/2023 | SRDX | Buy Now | Surmodics | $25.38 | 140.35% | Barrington Research | Michael Petusky | $70 → $61 | Maintains | Outperform | Get Alert |
| 04/28/2022 | SRDX | Buy Now | Surmodics | $25.38 | 81.25% | Needham | Mike Matson | $58 → $46 | Maintains | Buy | Get Alert |
| 02/04/2022 | SRDX | Buy Now | Surmodics | $25.38 | 128.53% | Needham | Mike Matson | $70 → $58 | Maintains | Buy | Get Alert |
| 11/10/2021 | SRDX | Buy Now | Surmodics | $25.38 | 175.81% | Needham | Mike Matson | — | Maintains | Buy | Get Alert |
| 09/08/2021 | SRDX | Buy Now | Surmodics | $25.38 | 199.45% | Needham | Mike Matson | — | Maintains | Buy | Get Alert |
FAQ
What is the target price for Surmodics (SRDX)?
The latest price target for Surmodics (NASDAQ: SRDX) was reported by Needham on April 10, 2024. The analyst firm set a price target for $47.00 expecting SRDX to rise to within 12 months (a possible 80.28% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Surmodics (SRDX)?
The latest analyst rating for Surmodics (NASDAQ: SRDX) was provided by Needham, and Surmodics reiterated their buy rating.
When was the last upgrade for Surmodics (SRDX)?
The last upgrade for Surmodics Inc happened on June 13, 2023 when Needham raised their price target to $36. Needham previously had a hold for Surmodics Inc.
When was the last downgrade for Surmodics (SRDX)?
The last downgrade for Surmodics Inc happened on February 13, 2023 when Needham changed their price target from N/A to N/A for Surmodics Inc.
When is the next analyst rating going to be posted or updated for Surmodics (SRDX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Surmodics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Surmodics was filed on April 10, 2024 so you should expect the next rating to be made available sometime around April 10, 2025.
Is the Analyst Rating Surmodics (SRDX) correct?
While ratings are subjective and will change, the latest Surmodics (SRDX) rating was a reiterated with a price target of $0.00 to $47.00. The current price Surmodics (SRDX) is trading at is $26.07, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.